Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Health care company Abbott is recalling approximately three million blood glucose sensors as there has been a fault found in ...

About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose ...

Investigational obesity medicine maridebart cafraglutide (Amgen) showed clinically meaningful and dose-dependent weight loss among adults with obesity, with or without type 2 diabetes (T2D), according ...

FGF19 triggers the brain to burn more energy and activate fat-burning cells, offering a potential new path for obesity ...

Based on the most recent statistics from the 2024 National Survey on Drug Use and Health, 48.4 million Americans (16.8%) aged ...

This article was reviewed by Felix Gussone, MD. Why Is Blood Work Important for Men’s Health? Key Takeaways Blood work gives ...

The intersection of tuberculosis (TB) and diabetes mellitus (DM) represents a pressing global health concern that demands ...

Abbott Diabetes Care has recalled certain glucose monitoring sensors after reports of seven deaths and more than 700 injuries possibly linked to malfunctioning devices that could provide inaccurate ...

For an average 30-year-old with type 1 or 2 diabetes, life expectancy was 14.2 and 7.9 years shorter, respectively, compared ...

These decisions may pose serious health risks, including potential injury or death," the FDA said in the alert.

The researchers discovered that people who took GLP-1 RAs had a higher chance of developing a chronic cough than those who ...